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resistance – is there a link? A longitudinal study
Abstract
Background: Serum thyroid stimulating hormone (TSH) 
levels are frequently elevated in obese children and are most 
likely to be associated with insulin resistance. However, 
clinical relevance of this association remains unclear.
Objectives: To assess the prevalence of hyperthyrotropine-
mia; to analyze the relationship between TSH and homeo-
stasis model assessment – insulin resistance (HOMA-IR); 
and to verify whether TSH levels and HOMA-IR vary with 
weight loss in obese children.
Subjects and Methods: Retrospective longitudinal study 
with data from baseline and 1 year after lifestyle inter-
vention in a pediatric obese group (344 children were 
recruited and 100 among them completed follow-up). For 
postintervention analysis, three groups were considered 
according to body mass index-standard deviation score 
(BMI-SDS) variations:  ≤  –0.5 (significant weight loss); 
0.5–0 (weight loss); and  > 0 (weight gain). Statistical anal-
ysis was performed using SPSS 19.0®.
Results: The prevalence of increased TSH levels was 9.3%. 
At baseline TSH (p = 0.007), fT4 (p = 0.006), and HOMA-IR 
(p < 0.001) were positively correlated to BMI-SDS (n = 344). 
Weight reduction was verified in 67 out of 100 cases but 
significant loss was present in only 21 cases. Decreases 
in both TSH and BMI-SDS were independently associ-
ated with decreases in HOMA-IR (p = 0.005 and p = 0.016, 
respectively). There was no correlation between TSH and 
BMI-SDS variation. Significant decreases in the HOMA-IR 
(p = 0.006) were only achieved in the significant weight 
loss group.
Conclusions: The prevalence of hyperthyrotropinemia 
was lower than previously reported. However, cutoff 
values were adjusted to pubertal stage, suggesting an 
over report in other studies. Insulin resistance and TSH 
were positively correlated, independent of body status. 
Although weight loss was not associated with TSH varia-
tion, a decrease in TSH levels was independently associ-
ated with decreases in HOMA-IR.
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Introduction
The growing prevalence of overweight and obesity is 
becoming an increasingly important health problem 
throughout the world, as obese children have greater 
likelihood than normal weight children to develop dys-
lipidemia, high blood pressure, and impaired glucose 
metabolism, which significantly increase their risk for 
cardiovascular and metabolic diseases (1–9).
Several endocrine abnormalities are reported due to 
obesity (9, 10). Some of these abnormalities are considered 
to be secondary effects of obesity and are usually restored 
after weight loss (10). Several studies report a positive 
correlation between serum levels of thyroid stimulating 
hormone (TSH) and body mass index (BMI) (1, 3–6, 9, 11–
14). These data suggest that thyroid function, even within 
the normal range, can be one of the several factors con-
tributing to determining body weight. Obese children may 
have moderately elevated TSH levels in association with 
normal or slightly elevated free thyroxine (fT4) and/or free 
triiodothyronine (fT3) levels, suggesting an adaptation 
process for increasing energy expenditure (1). Increased 
TSH levels, in obese children, have been reported to nor-
malize after substantial weight loss, but no overall con-
sensus has been reached (1, 3, 9, 14–17).
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The metabolic changes and increased cardiovascu-
lar risk described in the metabolic syndrome are very 
similar to the changes seen in hypothyroidism (1, 18). 
Some studies report that obese children with high TSH 
levels have more severe insulin resistance than obese 
children with normal TSH levels, with HOMA-IR posi-
tively correlating with TSH levels (5, 16). Some authors 
attribute this relationship to weight variation and not to 
thyroid function (1, 14).
There is still a considerable disagreement regarding 
thyroid dysfunction and other metabolic disorders in obese 
children, and whether these changes are reversible after 
weight reduction. In order to achieve a better understanding 
of this problem, we aimed: 1) to determine the prevalence of 
hyperthyrotropinemia in obese children and adolescents; 2) 
to verify whether TSH levels in childhood obesity are related 
to insulin resistance; and 3) to verify whether TSH levels and 
insulin resistance decrease with weight loss.
Materials and methods
A retrospective longitudinal study was conducted. Subjects were 
obese children and adolescents (2.4–19.8  years old) referred to the 
outpatient clinic at a tertiary hospital from 2008 to 2012 (5 years).
Subjects were excluded if they had endogenous obesity, hypo-
thyroidism, autoimmune thyroiditis, thyroid medication or steroids, 
diabetes or other endocrine disease, cancer, acute or chronic inflam-
matory diseases, or presence of any syndrome or disease known to 
affect body composition or fat distribution.
All anthropometric and biochemical measures were determined 
at baseline and at the end of the 1 year lifestyle modification program.
Anthropometric measures
Body weight was measured using an electronic digital balance (model 
910; Seca, Reinach, Switzerland) to the nearest 0.1 kg, in standing posi-
tion, in light clothing without shoes, with weight evenly distributed 
on both feet, according to the World Health Organization criteria (19). 
Height was measured to the nearest 0.1 cm with a stadiometer (model 
222; Seca), with the subject assuming the anthropometric position, 
placing the heels, buttocks, and back against the scale (20). The BMI 
was calculated as weight in kilograms divided by height in meters 
squared and obesity was defined as BMI over the 95th percentile for age 
and sex. To compare BMI values across different ages and by gender, 
we used BMI-standard deviation score (BMI-SDS) percentiles calcu-
lated according to the Center for Disease Control and Prevention growth 
charts (21). Pubertal stage was assessed according to Tanner’s criteria.
Biochemical assays
Blood samples were obtained after a 10-h overnight fast for the deter-
mination of glycemia, insulinemia, TSH, fT4, and fT3.
Insulin resistance was estimated by HOMA-IR = [fasting insulin 
(μU/mL) × fasting glucose (mmol/L)/22.5]. Increased insulin resist-
ance was present if HOMA-IR levels exceeded 2.5 (22).
Serum insulin was measured by chemiluminescent immunoas-
say (DXI Unicel 800, Beckman Coulter, Brea, CA, USA) and serum 
TSH, fT4, and fT3 levels were measured by chemiluminescent immu-
noassay (DXI Unicel 600, Beckman Coulter). The reference ranges for 
TSH were 0.55–6.2 and 0.52–3.7 μU/L, for fT4 were 0.8–1.72 and 0.6–
1.47 ng/dL, and for fT3 were 1.4–5.14 and 1.3–4.9 pg/dL, for children 
and pubertal individuals, respectively.
Lifestyle modification program
All subjects underwent a lifestyle modification program. Dietary 
guidelines were proposed to both subjects and parents, taking into 
account subject’s age and family dietary patterns; the adoption of 
a normocaloric Mediterranean diet, based on a balanced distribu-
tion of carbohydrates (55%), proteins (15%), and lipids (30% total, 
with  < 10% saturated fat) was prescribed. Aerobic exercise 3–5 times 
per week for at least 45–60  min was also recommended. Children 
were advised to reduce sedentary behavior (particularly television 
and video games) to  < 2 h per day.
The study protocol was approved by the Hospital’s Ethics Com-
mittee.
Statistical analysis
All values are presented as mean ± standard deviation or frequency 
distribution as appropriate. Dropout and nondropout subjects were 
compared at baseline. Continuous variables were compared with 
independent samples’ t test with Welch correction if equal variances 
could not be assumed. Categorical variables were compared with χ2 
test and significant differences were further analyzed with adjusted 
residuals. Bivariate Pearson correlations were calculated to analyze 
associations between thyroid function, BMI-SDS, and HOMA-IR at 
baseline. Multiple linear regression models were used to test asso-
ciations at baseline, controlling for age, gender, and pubertal state.
Taking into account previous studies where improvements in 
the metabolic profile only occurred in the presence of significant 
weight loss (i.e., a decrease  > 0.5 in BMI-SDS) (4, 5, 23), the sample 
was divided into three groups according to the degree of weight loss: 
increase in BMI-SDS; decrease in BMI-SDS between 0 and 0.5; and 
decrease in BMI-SDS  > 0.5.
Prepost intervention values were recorded and absolute differ-
ences (Δ) were used to measure intervention effects. Prepost mean 
differences between BMI-SDS groups were analyzed with the Kruskal-
Wallis test due to nonGaussian distribution. Posthoc analysis was 
conducted to examine significant differences between groups in 
which Kruskal-Wallis test was significant, with p-value adjustment 
for multiple comparisons. A p value  ≤  0.05 was considered significant. 
Data were analyzed with IBM SPSS 19.0® software (Armonk, NY, USA).
Results
Three hundred and forty-four patients were enrolled and 
100 (29.1%) among them completed the 1 year lifestyle 
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modification program. Clinical characteristics of the 
patients initially enrolled in the study are shown in Table 1. 
The causes of dropout included: loss of follow-up; absence 
of biochemical re-evaluation after the 1 year intervention; 
and development of exclusion criterion during follow-up.
No significant differences were found between 
dropout and nondropout subjects at baseline.
Association between variables at baseline
Baseline TSH and HOMA-IR levels were increased in 32 
(9.3%) and 239 (69.5%) subjects, respectively, with no sig-
nificant difference by sex. Pubertal subjects had a signifi-
cantly higher prevalence of hyperthyrotropinemia (13.8% 
vs. 1.6%, respectively, p < 0.001) and insulin resistance 
(77.9% vs. 55.1%, respectively, p < 0.001) than prepubertal 
subjects.
The HOMA-IR and fT3 levels were significantly differ-
ent between subjects with normal and elevated TSH levels 
(Table 2).
Significant positive correlations were found between 
TSH and both BMI-SDS (r = 0.146, p = 0.007) and HOMA-IR 
(r = 0.196, p < 0.001). The fT3 correlated positively with 
BMI-SDS (r = 0.202, p < 0.001) and negatively with HOMA-IR 
(r = –0.126, p = 0.019). The fT4 was only significantly cor-
related with BMI-SDS (r = 0.148, p = 0.006). A significant 
positive correlation was also found between HOMA-IR and 
BMI-SDS (r = 0.215, p < 0.001).
Multiple regression analysis confirmed the relation 
between TSH, as the dependent variable, and BMI-SDS 
Table 1 Baseline characteristics according to pubertal stage.
Prepubertal Pubertal
n 127 217
Male, % 54.3 47.5
Age, years 8.8 ± 2.2 13.4 ± 2.2
BMI-SDS 3.0 ± 0.7 2.9 ± 0.6
TSH, mU/L 2.7 ± 1.1 2.4 ± 1.2
fT3, ng/dL 4.5 ± 0.6 3.9 ± 0.4
fT4, pg/mL 1.2 ± 0.3 1.1 ± 0.4
HOMA-IR 2.9 ± 1.8 3.9 ± 2.3
Table 2 Association between studied variables and TSH levels.
Normal TSH High TSH p-Value
BMI-SDS 2.9 ± 0.7 3.0 ± 0.5 0.47
fT4, ng/dL 1.1 ± 0.4 4.4 ± 0.7 0.13
fT3, pg/mL 4.1 ± 0.5 4.4 ± 0.7 0.016
HOMA-IR 3.4 ± 2.0 5.0 ± 3.0 0.005
(p = 0.018), after controlling for age, gender, and pubertal 
state. The bivariate relation between fT4 (dependent vari-
able) and BMI-SDS was also confirmed (p = 0.024) while 
fT3 remained unrelated to BMI-SDS (p = 0.07). Regard-
ing insulin resistance, multiple regression analysis with 
HOMA-IR as the dependent variable showed significant 
and independent associations with BMI-SDS (p < 0.001) 
and TSH (p < 0.001) as shown in Figure 1.
Association between variables 
postintervention
After intervention, 67% of the followed-up children lost 
weight. Weight loss was significant (BMI-SDS varia-
tion  ≤  –0.5) in 21% of the sample.
Table 3 shows the characteristics of the intervention 
group at baseline and after 1 year of lifestyle intervention.
Multiple regression analysis did not show a link 
between TSH and BMI-SDS variation (p = 0.61). Neverthe-
less variations in both TSH and BMI-SDS were significantly 
and independently associated with HOMA-IR variation 
(p = 0.005 and p = 0.016, respectively), after controlling for 
age, gender, and pubertal state.
There were no significant differences in ΔTSH during 
the intervention in relation to the change in BMI-SDS 
(p = 0.97). Comparison of subjects’ ΔBMI-SDS groups 
showed significant differences in ΔHOMA-IR (p = 0.008). 
Post-hoc analysis showed significant differences between 
ΔHOMA-IR in the following two groups of ΔBMI-SDS: the 
( > 0) group and the ( ≤  –0.5) group (p = 0.006) (Table 4).
Discussion
The prevalence of increased plasma levels of TSH in our 
sample of obese children and adolescents was 9.3%. Due 
to the existence of multiple TSH assays and cutoffs it is 
difficult to directly compare results, but our prevalence is 
slightly lower than the previously reported value (10%–
23%) (1, 3–5, 7, 11, 13, 14, 16, 17). The trend of TSH levels 
to decrease with age has been previously described (12, 
24, 25). Therefore, we chose to use different cutoff values 
for prepubertal and pubertal children. Shalitin et  al. (4) 
described similar prevalences of hyperthyrotropinemia in 
prepubertal and pubertal individuals despite having used 
the same cutoff value in both.
We also found slightly increased fT3 and fT4 con-
centrations in 4.9% and 11% of the subjects, respectively. 
These findings are in agreement with other studies in 
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Figure 1 Baseline and postintervention associations between TSH and HOMA-IR.
Table 3 Characteristics of the intervention group.
Baseline 13 year
BMI-SDS 3.0 ± 0.7 2.8 ± 0.7
TSH, mU/L 2.7 ± 1.3 2.7 ± 1.5
fT4, ng/dL 1.2 ± 0.4 1.1 ± 0.5
fT3, pg/mL 4.2 ± 0.5 4.0 ± 0.4
HOMA-IR 3.6 ± 2.0 3.7 ± 2.3




n 33 46 21
ΔTSH, mU/L 0.03 ± 1.81 –0.10 ± 1.22 0.04 ± 1.56 0.97
ΔfT4, ng/dL –0.07 ± 0.45 –0.07 ± 0.57 –0.04 ± 0.34 0.69
ΔfT3, pg/mL –0.20 ± 0.43 –0.13 ± 0.55 –0.16 ± 0.57 0.83
ΔHOMA-IR 1.05 ± 2.93 –0.03 ± 1.91 –0.86 ± 1.94 0.008
aKruskal-Wallis test.
children and adults, although usually with a greater pro-
portion of elevated fT3 levels than fT4 levels (1, 3, 6, 8, 13, 
17, 26). All studied thyroid function parameters showed a 
significantly positive correlation with BMI-SDS, but only 
TSH and fT4 remained significant in the regression analy-
sis. These findings are in line with several cross-sectional 
and longitudinal studies which have found a positive rela-
tionship between weight status and thyroid function in 
obese children (1, 3–6, 9, 11, 13, 14, 16, 27).
To explain the potential defects of thyroid function 
in obesity several underlying mechanisms have been 
hypothesized, including iodine deficiency, autoimmune 
thyroiditis, mutations in the TSH-receptor gene, increased 
leptin-mediated production of prothyrotropin releas-
ing hormone (TRH), impaired feedback due to a lowered 
number of T3 receptors in the hypothalamus (thyroid 
hormone resistance), and variations in deiodinase activ-
ity (1, 3, 4, 8). The slight increase in TSH levels is usually 
not associated with iodine deficiency or autoimmune 
thyroiditis (3, 9, 16). Furthermore, nonsynonymous muta-
tions in the TSH-receptor gene are rare (3). Thus, the most 
favored hypothesis attempting to explain the increased 
TSH levels in obesity is the increased leptin-mediated 
production of pro-TRH (3, 6, 9, 28). Leptin stimulates TSH 
production acting through the hypothalamic-pituitary 
axis (3, 9, 17). It has been recently reported that leptin 
signaling, mediated by JAK/STAT pathway, is mandatory 
for the maintenance of TRH expression in the hypotha-
lamic paraventricular nucleus and thus, for normal pro-
duction of TSH and thyroid hormones (9, 11, 14, 17, 28). 
This finding is corroborated by our results, as our obese 
patients with hyperthyrotropinemia showed significantly 
higher fT3 values. Furthermore, studies in animal models 
demonstrate that leptin can decrease deiodinase activ-
ity in pituitary tissue, thus modifying the feedback of T3 
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on TSH secretion (3, 8, 9, 28). At the same time, TSH may 
stimulate leptin production by adipocytes, suggesting a 
cross-talk between these two hormones (3).
Thyroid hormones are important determinants of 
glucose homeostasis (1). The influence of insulin resist-
ance, often present in obese patients, on the hypotha-
lamic-pituitary-thyroid axis has been investigated, but 
conflicting results have been reported (1). The prevalence 
of HOMA-IR elevation in our sample was nearly 70% and 
this prevalence was higher among pubertal subjects. We 
found that obese children with hyperthyrotropinemia had 
increased insulin resistance and, even within the normal 
range, TSH and HOMA-IR showed a positive correla-
tion. These findings are in agreement with other studies 
in adults and children (6, 7, 13, 16, 27, 29). However, it is 
difficult to prove a causal relationship between thyroid 
hormones and insulin resistance in obesity as both are 
influenced by weight status and, after adjustment for BMI, 
most of these relationships are not significant any longer 
(1, 6). In our sample, significant bivariate associations 
were found between thyroid hormones, BMI-SDS, and 
insulin resistance. The association between TSH and the 
insulin resistance index remained significant even after 
adjusting for BMI-SDS.
Experimental studies suggest that thyroid hormones 
may impact insulin sensitivity by influencing expression 
or activation of uncoupling protein, β adrenergic recep-
tor, and peroxisome proliferator-activated receptor-γ (27). 
Contrasting results were reported by other authors who 
did not detect any association between TSH levels and 
HOMA-IR (5, 14).
One hundred children completed 1 year of lifestyle 
modification – 67% of them achieving weight reduction. 
However, only 21% had a substantial weight decrease, a 
result that is in line with other reports (1). This result may 
be the reason why the studied biochemical parameters 
remained unchanged overall (Table 4). Like several other 
studies (4, 13, 14, 17, 30) we did not find an association 
between BMI-SDS variation and TSH, even after substan-
tial weight loss (BMI-SDS variation  ≤  –0.5).
Contrary to adults (2, 15, 18, 31–33), the role of thyroid 
hormones in glucose dysmetabolism in otherwise healthy 
obese children has been examined to a limited extent. In 
our pediatric population, both BMI-SDS and TSH varia-
tions were independently associated with HOMA-IR vari-
ation. Nevertheless, a slight reduction in weight (BMI-SDS 
decrease  < 0.5) was not associated with decrease in HOMA-
IR, suggesting that a substantial weight reduction is 
required to modify insulin resistance. A previous study in 
obese children, in which weight loss significantly reduced 
TSH, did not find an association between TSH and changes 
in insulin sensitivity (11). These data contrast with another 
study, in which the decrease in TSH, rather than changes 
in body weight or composition, was the main determinant 
of improvements in fasting insulin and HOMA-IR (16). 
Although these data suggest that interventions to decrease 
TSH concentrations during weight loss in obese subjects 
could be beneficial in further increasing insulin sensitiv-
ity, in the pediatric setting there are no controlled studies 
looking at outcomes of obese children with elevated TSH 
levels treated with thyroxine vs. those given placebo (1, 
3). The few available data are derived from anecdotal case 
reports and a small series of cases in which no beneficial 
effects on body weight, BMI, linear growth, and body lipids 
were found in treated subjects, suggesting that thyroid 
substitution is not necessary in most cases (1, 3, 9, 28).
Our study is not without limitations. First, the lack of 
significant differences of changes in TSH levels during the 
weight reduction interventions in relation to the change 
in BMI-SDS may be affected by the small number of par-
ticipants in each of the subgroups. Second, BMI percen-
tiles were used to classify overweight. Although BMI is 
a good measure for overweight, it has limitations as an 
indirect measurement of adiposity. Measurement of body 
composition would be the ideal. However, the gold stand-
ards such as dual-energy X-ray absorptiometer or indirect 
calorimetry are very difficult to perform in a large group 
of obese children. Finally, we did not differentiate the 
effect of diet and increased physical exercise. In contrast 
to exercise-induced weight loss, diet-induced weight loss 
has been reported to be associated with changes in thyroid 
hormone production (34).
In this study, the prevalence of hyperthyrotropinemia 
was lower than previously reported. Nevertheless, and for 
the first time, different cutoff values for prepubertal and 
pubertal children were used, suggesting an over diagno-
sis of hyperthyrotropinemia in prior studies. At baseline, 
we found a positive correlation between TSH levels and 
insulin resistance, independent of body status. One year 
after the introduction of lifestyle changes, weight loss was 
related to a significant reduction of HOMA-IR. Although 
the TSH variation in the weight loss group was not sig-
nificant, it was associated with the HOMA-IR variation. 
Whether TSH is responsible for HOMA-IR variations or the 
opposite is yet to be clarified.
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